Back to 
RTW Investments, LP
RTW Investments, LP
ALNY
Showing 0 of 21 quarters
Position history for RTW Investments, LP's holdings in Alnylam Pharmaceuticals, Inc.
No. RTW Investments exited its ALNY (Alnylam Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 1,640,559 shares worth $314M. RTW Investments already held ALNY in its Q1 2019 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.